logo

FDA Calendar

Share
Company Name Heron Therapeutics Inc.
Drug Name HTX-011 (NDA)
Event Name FDA decision on HTX-011 for the management of postoperative pain
Event Date 04/30/2019
Outcome Date
Outcome FDA issues Complete Response Letter for HTX-011 on May 1
Drug Status Priority review
Rival Drugs
Market Potential
Other Approvals
News
Return to FDA Calendar